D-1036-2017 Class II Terminated

Recalled by Apace KY LLC — Fountain Run, KY

FDA drug recall D-1036-2017 was initiated by Apace KY LLC on Jun 19, 2017 and is designated Class II. Reason for recall: Labeling; Label Mix up; cartons labeled as Amantadine HCl 100 mg Capsules contain unit dose blister cards of Cyclobenzaprine HCl Tablet, USP 5 mg The recall status is terminated (terminated May 4, 2018).

Recall details

Product Type
Drugs
Report Date
Aug 9, 2017
Initiation Date
Jun 19, 2017
Termination Date
May 4, 2018
Voluntary/Mandated
Voluntary: Firm initiated

Product description

Cyclobenzaprine HCl Tablets, USP, 5 mg, 50 Tablets (5x10) Unit Dose Cartons, Rx Only, Manufactured for: AvKARE Inc, Pulaski, TN 38478 --- NDC: 50268-0190-15

Reason for recall

Labeling; Label Mix up; cartons labeled as Amantadine HCl 100 mg Capsules contain unit dose blister cards of Cyclobenzaprine HCl Tablet, USP 5 mg

Distribution pattern

KY

Code information

Lot: 16710, exp 07/2018

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1036-2017
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1036-2017. Report a data issue: hello@regdatalab.com.